|
Dr. Xavier is a Vice President, with Johnson & Johnson Development Corporation, Johnson & Johnson’s venture arm. Dr. Xavier is based in New Brunswick, NJ and represents JJDC on the board of a number of its portfolio companies. Dr. Xavier previously worked in business development at BioRexis Pharmaceutical Corporation, King of Prussia, PA (recently acquired by Pfizer). While at BioRexis, he assisted the company in raising a $30 million second round of financing. He has worked in business development and strategy at SGX Pharmaceuticals (San Diego, CA; SGXP) and was a project leader at Message Pharmaceuticals (Malvern, PA). Dr. Xavier holds an MBA from The Wharton School at the University of Pennsylvania, where he graduated with honors. He holds a B.Tech. from the Indian Institute of Technology (Kanpur, India) and a Ph.D. from the University of Houston both in Chemical Engineering. He was a postdoctoral research fellow in the Department of Chemistry at John Hopkins University. | 